Tempus AI · 9 hours ago
Science Strategy Leader
Chicago, IL
Full-time
Onsite
Director/Executive
$192K/yr - $264K/yr
10+ years expTempus AI is a company focused on precision medicine and advancing the healthcare industry through AI-driven insights. They are seeking a visionary Science Strategy Leader to spearhead scientific strategy and executive engagement with Pharma and Biotech partners, ensuring collaborations drive innovation and deliver value.
Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPrecision Medicine
Responsibilities
Serve as the executive scientific lead for strategic Pharma/Biotech partnerships, shaping account-level and portfolio-wide strategies in alignment with corporate priorities
Lead Joint Steering Committees (JSCs), ensuring data-driven decision-making and alignment between partner needs and our capabilities
Champion the integration of novel scientific insights—including real-world, clinical, genomic, and multimodal data—into ongoing collaborations to accelerate innovation
Lead development and positioning of emerging offerings (e.g., LOOP)
Create structured pathways for knowledge sharing between Account VPs, KADs, Translational Research, Pharma R&D, RWD, and SOS teams to ensure strategic continuity from pre- to post-contract
Guide teams in identifying strategic opportunities, anticipating partner needs, and translating scientific advances into new collaborations with our partner biotechs/pharma companies
Strengthen and scale programs like ‘Sparks’, enabling KADs/SSLs to communicate high-impact scientific narratives tailored to partner priorities
Partner with R&D leaders to ensure that insights from translational science inform ongoing and future clinical programs
Promote best practices in leveraging real-world and multimodal evidence to enhance development timelines and success rates
Develop and champion new data-driven use cases for multimodal data integration into trial design, patient stratification, and regulatory engagement
Identify expansion opportunities within accounts by linking emerging science to unmet partner needs
Ensure strategic alignment across multiple accounts to leverage cross-account insights for scalable growth
Drive measurable improvement in partner satisfaction, time to value realization, and account renewal/expansion rates
Qualification
Required
10+ years in pharma/biotech with demonstrated experience in research, clinical development, and commercial strategy
Proven cross-functional leadership in a matrix environment, ideally with global and multi-asset portfolio oversight
Demonstrated expertise in data-driven clinical innovation, including familiarity with core scientific modalities (e.g., genomics, proteomics, digital pathology, imaging) and their integration into multimodal strategies
Track record of success in executive partner engagement, including governance structures (e.g., JSCs) and joint portfolio planning
Ability to translate complex scientific and data insights into actionable strategies for diverse stakeholders, including C-suite and external partners
Exceptional communication, negotiation, and influencing skills, with experience managing high-value, high-impact relationships
Advanced degree (PhD, MD, PharmD, or equivalent) required
Preferred
MBA or business leadership training a plus
Benefits
Incentive compensation
Restricted stock units
Medical and other benefits
Company
Tempus AI
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.
1001-5000 employees
H1B Sponsorship
Tempus AI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$2.29BKey Investors
Ares ManagementGoogleBaillie Gifford
2025-06-30Post Ipo Debt· $650M
2025-02-19Post Ipo Debt· $300M
2024-06-14IPO
Leadership Team
Eric Lefkofsky
Founder and CEO
Shane Colley
CTO
Recent News
Business Wire
2026-01-22
2026-01-13
Business Wire
2026-01-13
Company data provided by crunchbase